PI3K/AKT/mTOR signaling pathway | |||||||
---|---|---|---|---|---|---|---|
Pathway | Cancer | CircBase name | Location | Regulation | Mechanism | Putative function | |
PI3K/AKT/mTOR | CRC | circCDYL | C | Down | miR sponge/ceRNA | circCDYL/miR-150-5p promotes apoptosis | Represses cellular growth and migration |
circ_0001313 | NI | Up | circ-0001313/miR-510-5p/AKT2 axis | Promotes development and progression of cancer | |||
hsa_circ_002144 | C | Up | hsa_circ_002144/miR-615-5p/LARP1/mTOR axis | Promotes growth and metastasis | |||
circIL4R | C | Up | circIL4R/miR-761/TRIM29/PHLPP1 | Promotes proliferation and metastasis | |||
GC | circNRIP1 | C | Up | circNRIP1/miR-149-5p/AKT1/mTOR | Promotes GC proliferation, migration, and invasion | ||
Glioma | circ_0014359 | C | Up | circ_0014359/miR-153/PI3K | Promotes glioma progression | ||
NSCLC | circFGFR3 | NI | Up | circFGFR3/miR-22-3p/Galectin-1-AKT/ERK1/2 signaling | Galectin-1-AKT/ERK1/2 signaling | ||
HCC | circRNA-100338 | C | Up | circRNA-100338/miR-141-3p/RHEB/mTOR | Poor prognosis | ||
Ovarian cancer | circPLEKHM3 | C | Down | circPLEKHM3/miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis | Inhibits cell growth, migration, and EMT | ||
Breast cancer | circKDM4B | C | Down | circKDM4B/miR-675/NEDD4L | Inhibits cell angiogenesis and tumor metastasis | ||
PTC | circ_0067934 | NI | Up | circ_0067934/miR-1301-3p/PI3K/AKT signaling pathway | Promotes cancer progression | ||
Pancreatic cancer | circ-ANAPC7 | C | Down | circ-ANAPC7/miR-373/PHLPP2 | Inhibits muscle wasting and cancer cachexia | ||
CRC | circ_LNLM | C | Up | Scaffold/binding with AKT | Blocks ubiquitination of AKT | Promotes the early metastasis especially for lymph node-negative CRC patients with synchronous liver metastasis | |
OSCC | circ_0007059 | NI | Down | Epigenetic modification | AKT/mTOR signaling pathway | Suppresses cell growth, migration, and invasion; facilitates apoptosis | |
Glioblastoma | circ-AKT3 | C | Down | Translation | AKT3-174 aa competitively interacts with phosphorylated PDK1 | Inhibits glioblastoma tumorigenicity |
Wnt/β-catenin signaling pathway | |||||||
---|---|---|---|---|---|---|---|
Pathway | Cancer | CircBase name | Location | Regulation | Mechanism | Putative function | |
Wnt/β-catenin | CRC | hsa_circ_0000523 | NI | Down | miR sponge/ceRNA | hsa_circ_0000523Wnt/β-catenin | Inhibits cancer progression |
hsa_circ_0009361 | C | Down | hsa_circ_0009361/miR-582/APC2 network | Induces cancer progression and EMT | |||
circRNA_100290 | NI | Up | circRNA_100290/miR-516b/FZD4/Wnt/β-catenin | Oncogenic function | |||
DLBL | circEAF2 | NI | Up | miR-BART19-3p/APC/β-catenin axis | Oncogenic function | ||
EC | hsa_circ_0002577 | NI | Up | miR-197/CTNND1 axis, Wnt/β-catenin pathway | Oncogenic function | ||
Glioma | hsa_circ_0000177 | NI | Up | hsa_circ_0000177/miR-638/FZD7-Wnt | Promotes cancer proliferation and invasion | ||
Bladder cancer | circPRMT5 | C | Up | circPRMT5/miR-30c/Snail/E-cadherin | EMT and cancer metastasis | ||
Lung cancer | circ_0007059 | NI | Down | circ_0007059/miR-378/Wnt/β-catenin | Inhibits progression and EMT process | ||
GC | circAXIN1 | C | Up | Translation | Competitively interacts with APC | AXIN1-295 aa promotes GC progression | |
TNBC | circ-EIF6 | C | Up | circ-EIF6/EIF6-224 aa/MYH9/Wnt/β-catenin | Promotes TNBC progression | ||
Liver cancer | circβ-catenin | C | Up | Stabilizes full-length β-catenin by antagonizing degradation | Promotes liver cancer cell growth | ||
Colon cancer | circFNDC3B | C | Down | circFNDC3B-218 aa/Snail/FBP1 | Inhibits cell proliferation, invasion, migration, and EMT | ||
RCC | circESRP1 | C | Down | Feedback loop | circESRP1/miR-3942/CTCF/c-Myc/EMT | Inhibits cell proliferation and EMT | |
HCC | circ-ZNF652 | C | Up | circ-ZNF652/miR-203/Snail feedback loop | EMT and cancer metastasis | ||
circ-ZNF652/miR-502-5p/Snail feedback loop | EMT and carcinoma metastasis | ||||||
PTC | circRNA_102171 | N | Up | TF | Modulates CTNNBIP1-dependent activation of the β-catenin pathway | Promotes PTC progression | |
LSCC | circMTCL1 | C | Up | Inhibits C1QBP ubiquitin degradation | Promotes progression |
Notch and Hippo signaling pathways | |||||||
---|---|---|---|---|---|---|---|
Pathway | Cancer | CircBase name | Location | Regulation | Mechanism | Putative function | |
Notch | Glioma | circNFIX | NI | Up | miR sponge/ceRNA | circNFIX/miR-34a-5p/NOTCH1 pathway | Oncogenic function |
LADC | circ-MTO1 | NI | Down | circ-MTO1/miR-17/QKI-5 feedback loop | Negatively regulates LUAD | ||
Breast cancer | circFAT1 | NI | Up | circFAT1/miR-525-5p/spindle | Promotes cancer cell metastasis | ||
PDAC | circ-ASH2L | C | Up | circ-ASH2L/miR-34a | Oncogenic function | ||
CRC | circAPLP2 | NI | Up | circAPLP2/miR-101-3p inhibits apoptosis | Promotes proliferation and metastasis | ||
T-ALL | circPVT1 | NI | Up | circPVT1/miR-30e/DLL4 | Promotes cell proliferation | ||
RCC | circPDK1 | C | Up | circPDK1/miR-377-3P-NOTCH1 | Promotes RCC cell migration and invasion | ||
Hippo | GC | circRNA-000425 | NI | Down | miR sponge/ceRNA | YAP1/circRNA-000425/miR-17 and miR-106 | Inhibits cancer cell growth |
HCC | circ_104075 | NI | Up | circ_104075/miR-582-3p/YAP1 | Oncogenic function | ||
Osteosarcoma | circPIP5K1A | NI | Up | circPIP5K1A/miR-515-5p/YAP axis | Promotes cancer cell invasion and migration, and cancer stemness | ||
ICC | circACTN4 | N and C | Up | circACTN4/miR-424-5p/YBX1/FZD7 | Promotes tumor progression | ||
CRC | circ-LECRC | C | Down | Feedback loop | circ-LECRC/miR-135b-5p/KLF4; suppresses activation of YAP signaling | Inhibits tumor growth | |
Colon cancer | circPPP1R12A | C | Up | Translation | circPPP1R12A-73 aa/Hippo-YAP | Promotes tumor pathogenesis and metastasis | |
CRC | circ1662 | C | Up | Nuclear accumulation | Promotes YAP1 nuclear accumulation and regulates smad3 | Promotes CRC cell invasion and migration | |
Breast cancer | circYap | NI | Down | circYap/eIF4G/PABP; negatively regulates YAP translation | Inhibits tumor growth |
p53/Bcl2 signaling pathway | |||||||
---|---|---|---|---|---|---|---|
Pathway | Cancer | CircBase name | Location | Regulation | Mechanism | Putative function | |
p53/Bcl2 | NSLC | circVANGL1 | NI | Up | miR sponge/ceRNA | circVANGL1/miR-195/Bcl-2 axis | Inhibits proliferation and induced apoptosis |
HCC | circ-BIRC6 | C | Up | circ-BIRC6/miR-3918/Bcl2 axis | Oncogenic function | ||
CRC | circ_0021977 | NI | Down | circ_0021977/miR-10b-5p/p21/p53 axis | Suppresses cancer proliferation, migration, and invasion | ||
HNSCC | circPVT1 | NI | Up | circPVT1/miR-497-5p/mut-p53/YAP/TEAD complex | Oncogenic function | ||
NSCLC | hsa_circ_0002874 | NI | Up | hsa_circ_0002874/miR-1273f/MDM2/p53 | Promotes resistance of NSCLC | ||
GC | hsa_circ_006100 | NI | Up | hsa_circ_006100/miR-195/GPRC5A/Bcl-2 axis | Oncogenic function | ||
Osteosarcoma | circ_0001785 | NI | Up | circ_0001785/miR-1200/HOXB2/Bcl-2 family | Oncogenic function | ||
OSCC | hsa_circ_0055538 | NI | Down | Apoptosis | p53/Bcl-2/caspase signaling pathway | Inhibits tumor growth | |
Osteosarcoma | circ_0007534 | NI | Up | Bcl-2/caspase-3, AKT/GSK-3β pathway | Regulates cancer growth and apoptosis | ||
CRC | circZNF609 | C | Down | circZNF609/p53 | Promotes cancer apoptosis | ||
Glioma | circCHAF1A | NI | Up | Feedback loop | circCHAF1A/miR-211-5p/HOXC8/MDM2-p53 | Facilitates glioma proliferation and tumorigenesis | |
CDR1as | N | Down | Disruption of the p53/MDM2 complex | CDR1as directly interacts with p53 | Inhibits gliomagenesis | ||
Breast cancer | circ-Ccnb1 | NI | Down | mut-p53 | circ-Ccnb1/H2AX/Bclaf1 complex inhibits mut-p53 | Inhibits breast cancer progression | |
circ-DNMT1 | NI | Up | p53 nuclear translocation | Binding to p53 promotes nuclear translocation of both p53 and AUF1 | Enhances breast cancer progression |
TGF-β/Smad signaling pathway inducing EMT | |||||||
---|---|---|---|---|---|---|---|
Pathway | Cancer | CircBase name | Location | Regulation | Mechanism | Putative function | |
TGF-β/Smad | Bladder cancer | circRIP2 | C | Down | miR sponge/ceRNA | circRIP2/miR-1305/TGF-β2/smad3 | EMT and cancer progression |
NSCLC | circPTK2 | C | Down | circPTK2/miR-429/miR-200b-3p/TGF-β/Smad | Inhibits EMT and metastasis | ||
OSCC | circANKS1B | C | Up | circANKS1B/miR-515-5p | Affects metastatic potential, EMT, and cisplatin resistance | ||
TNBC | circANKS1B | C | Up | circANKS1B/miR-148a-3p and miR-152-3pUSF1/TGF-β1/Smad | EMT and metastasis | ||
ESCC | circ-DOCK5 | C | Down | Feedback loop | ZEB1/circ-DOCK5/miR-627-3p/TGF-β/Smad | EMT and metastasis | |
OSCC | circUHRF1 | C | Up | circUHRF1/miR-526b-5p/c-Myc/TGF-β1/ESRP1 feedback loop | Accelerates EMT and tumorigenesis | ||
CRC | circPTEN1 | C and N | Down | Decreases nuclear translocation of Smad complexes | Suppresses cancer progression and EMT |
C, cytoplasm; N, nucleus; NI, not investigated.